• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4597353)   Today's Articles (3095)   Subscriber (49353)
For: Bizzaro F, Marchetti AC, Decio A, Ricci F, O'Connor MJ, Taylor MA, Lai Z, Barry ST, Bani MR, Giavazzi R. Abstract 2816: Patient derived ovarian cancer xenograft (OC-PDX) to study the response of the PARP inhibitor olaparib. Cancer Res 2018. [DOI: 10.1158/1538-7445.am2018-2816] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Number Cited by Other Article(s)
1
Olaparib Tablet: A Review in Ovarian Cancer Maintenance Therapy. Target Oncol 2018;13:801-808. [DOI: 10.1007/s11523-018-0606-x] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA